Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

Healthcare Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

NDAQ:IPA - Post Discussion

Immunoprecise Antibodies Ltd > Big week...start of news releases?
View:
Post by wallpaper2 on Dec 11, 2022 3:08pm

Big week...start of news releases?

AGM Dec 13th.  Revenue update Dec 15th. 2023 anticipated rollouts with very large $$$$ attatched.
The wait could be over.
Comment by kepiyal on Dec 12, 2022 1:18am
This post has been removed in accordance with Community Policy
Comment by wallpaper2 on Dec 14, 2022 11:20am
SMMT ...Summit Therapeutics just signed a contract with a Chinese Antibody Research Co that included a $500 million upfront payment and a further $4.5 billion royalty agreement. Summit is presenting at next months JP Morgan conference in San Fransisco alongside IPA. The Chinese Co is starting Phase 3 trials targeting cancers. IPA is also targeting cancer and several other major Health conditions.& ...more  
Immunoprecise Antibodies Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities